Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menotti Ruvo

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|April 3, 2021
Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer InterferometryJwala Priyadarsini Sivaccumar, Antonio Leonardi, Emanuela Iaccarino, et al.
Glycoconjugate Journal|December 12, 2019
Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnosticThais Canassa-DeLeo, Vanessa Leiria Campo, Lílian Cataldi Rodrigues, et al.
Mabs|August 26, 2016
Monoclonal antibodies against pools of mono- and polyacetylated peptides selectively recognize acetylated lysines within the context of the original antigenAnnamaria Sandomenico, Annalia Focà, Luca Sanguigno, et al.
Cancers|October 23, 2021
Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19Carla L Esposito, Katrien Van Roosbroeck, Gianluca Santamaria, et al.
Bioorganic & Medicinal Chemistry|October 17, 2017
Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasionMarcelo Fiori Marchiori, Thalita B Riul, Leandro Oliveira Bortot, et al.
International Journal of Biological Macromolecules|June 19, 2026
A new trastuzumab-ageritin-based immunotoxin that specifically kills breast cancer cellsAngela Oliver, Nicola Landi, Emanuela Iaccarino, et al.
Oncotarget|April 15, 2015
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer modelsValeria Cicatiello, Ivana Apicella, Laura Tudisco, et al.
Peptides|January 29, 2017
Trifluoroacetylated tyrosine-rich D-tetrapeptides have potent antioxidant activityAnnamaria Sandomenico, Valeria Severino, Fabio Apone, et al.
Oncotarget|October 27, 2017
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cellsIlaria Cimmino, Virginia Lorenzo, Francesca Fiory, et al.
Cell Death & Disease|November 1, 2018
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatmentLaura Mercurio, Martina Morelli, Claudia Scarponi, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|April 3, 2021
Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer InterferometryJwala Priyadarsini Sivaccumar, Antonio Leonardi, Emanuela Iaccarino, et al.
Glycoconjugate Journal|December 12, 2019
Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnosticThais Canassa-DeLeo, Vanessa Leiria Campo, Lílian Cataldi Rodrigues, et al.
Mabs|August 26, 2016
Monoclonal antibodies against pools of mono- and polyacetylated peptides selectively recognize acetylated lysines within the context of the original antigenAnnamaria Sandomenico, Annalia Focà, Luca Sanguigno, et al.
Cancers|October 23, 2021
Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19Carla L Esposito, Katrien Van Roosbroeck, Gianluca Santamaria, et al.
Bioorganic & Medicinal Chemistry|October 17, 2017
Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasionMarcelo Fiori Marchiori, Thalita B Riul, Leandro Oliveira Bortot, et al.
International Journal of Biological Macromolecules|June 19, 2026
A new trastuzumab-ageritin-based immunotoxin that specifically kills breast cancer cellsAngela Oliver, Nicola Landi, Emanuela Iaccarino, et al.
Oncotarget|April 15, 2015
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer modelsValeria Cicatiello, Ivana Apicella, Laura Tudisco, et al.
Peptides|January 29, 2017
Trifluoroacetylated tyrosine-rich D-tetrapeptides have potent antioxidant activityAnnamaria Sandomenico, Valeria Severino, Fabio Apone, et al.
Oncotarget|October 27, 2017
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cellsIlaria Cimmino, Virginia Lorenzo, Francesca Fiory, et al.
Cell Death & Disease|November 1, 2018
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatmentLaura Mercurio, Martina Morelli, Claudia Scarponi, et al.
Pageof 15